Market Place
Sourcing Support
Axogen, Inc. to report Q1 2025 financial results on May 8, 2025
24 Apr 2025 //
GLOBENEWSWIRE
Axogen appoints Rick Ditto as VP, Global Health Economics
24 Mar 2025 //
GLOBENEWSWIRE
Axogen, Inc. To Host Analyst & Investor Day on March 4th
25 Feb 2025 //
GLOBENEWSWIRE
Axogen to report 2024 Q4 & full year financial results on Feb 25
11 Feb 2025 //
GLOBENEWSWIRE
Axogen Announces Appointment of Jesse Bishop as Vice President
03 Feb 2025 //
GLOBENEWSWIRE
Axogen Reports Preliminary Revenue For Q4 And Full-Year 2024
10 Jan 2025 //
GLOBENEWSWIRE
Axogen Names New VP Of Operations & Announces Inducement Grant
10 Jan 2025 //
GLOBENEWSWIRE
Axogen, Inc Reports Q3 2024 Financial Results & BLA Update
07 Nov 2024 //
GLOBENEWSWIRE
Axogen To Report Q3 2024 Results On Nov 7, 2024
24 Oct 2024 //
GLOBENEWSWIRE
Axogen Reports Inducement Grant Under NASDAQ Rule 5635(c)(4)
03 Sep 2024 //
GLOBENEWSWIRE
Axogen, Inc. Reports Second Quarter 2024 Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
Axogen, Inc. Announces New Leadership Appointments
08 Aug 2024 //
GLOBENEWSWIRE
Axogen To Report Q2 2024 Results On August 8
23 Jul 2024 //
GLOBENEWSWIRE
Company Reports Inducement Grants Under Nasdaq Rule 5635(C)(4)
01 Jul 2024 //
GLOBENEWSWIRE
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
24 Jun 2024 //
GLOBENEWSWIRE
Axogen: Ohio Processing Center Opening Celebrated With State Leaders
28 May 2024 //
GLOBENEWSWIRE
Axogen Initiates Rolling BLA For Avance Nerve Graft
16 May 2024 //
GLOBENEWSWIRE
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
14 May 2024 //
GLOBENEWSWIRE
Axogen, Inc Reports First Quarter 2024 Financial Results
02 May 2024 //
GLOBENEWSWIRE
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix„
29 Apr 2024 //
GLOBENEWSWIRE
Axogen to Report Q1 2024 Results, Host Conference Call on May 2, 2024
16 Apr 2024 //
GLOBENEWSWIRE
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
05 Mar 2024 //
GLOBENEWSWIRE
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results
13 Feb 2024 //
GLOBENEWSWIRE
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02 Feb 2024 //
GLOBENEWSWIRE
Axogen, Inc. Announces Positive Topline Results from REPOSE
18 Jan 2024 //
GLOBENEWSWIRE
Axogen Announces Promotions on Research and Development Team
04 Jan 2024 //
GLOBENEWSWIRE
Axogen Announces Plan for Leadership Transition
04 Jan 2024 //
GLOBENEWSWIRE
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter & Full-Year 2023
04 Jan 2024 //
GLOBENEWSWIRE
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
26 Dec 2023 //
GLOBENEWSWIRE
Axogen Announces Transition of Finance Team Leadership
06 Dec 2023 //
GLOBENEWSWIRE
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2023 //
GLOBENEWSWIRE
Axogen to Participate at the Piper Sandler 35th Annual Healthcare Conference
20 Nov 2023 //
GLOBENEWSWIRE
Axogen, Inc. Reports 2023 Third Quarter Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Axogen, Inc. to Report Third Quarter 2023 Financial Results
18 Oct 2023 //
GLOBENEWSWIRE
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector„¢
05 Sep 2023 //
GLOBENEWSWIRE
Axogen to Participate at Upcoming Investor Conferences
31 Aug 2023 //
GLOBENEWSWIRE
Axogen Begins Processing Avance Nerve Graft at New Facility in Dayton
21 Aug 2023 //
GLOBENEWSWIRE
Axogen, Inc. Reports 2023 Second Quarter Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
Axogen to Participate at Canaccord Genuity™s 43rd Annual Growth Conference
27 Jul 2023 //
GLOBENEWSWIRE
Axogen, Inc. to report second quarter 2023 financial results
26 Jul 2023 //
GLOBENEWSWIRE
Axogen to Participate at Jefferies Healthcare Conference
24 May 2023 //
GLOBENEWSWIRE
Axogen to Participate at JMP Securities Life Sciences Conference
12 May 2023 //
GLOBENEWSWIRE
Axogen, Inc. Reports 2023 First Quarter Financial Results
09 May 2023 //
GLOBENEWSWIRE
Axogen, Inc. to report 1Q 2023 FYR and host conference call on May 9, 2023
18 Apr 2023 //
GLOBENEWSWIRE
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
14 Mar 2023 //
GLOBENEWSWIRE
Axogen Appoints Marc Began as Executive Vice President and General Counsel
06 Mar 2023 //
GLOBENEWSWIRE
Axogen, Inc. to report fourth quarter 2022 financial results
02 Mar 2023 //
GLOBENEWSWIRE
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
13 Feb 2023 //
GLOBENEWSWIRE
Axogen Reports Preliminary Unaudited Revenue for Q4 and Full-Year 2022
09 Jan 2023 //
GLOBENEWSWIRE
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
04 Jan 2023 //
GLOBENEWSWIRE
